View All Documents & Correspondence
A Herbal Composition, And Implementations Thereof
Abstract: The present disclosure describes a composition comprising: (a) Ocimum sanctum extract; (b) Phaseolus vulgaris extract, and; (c) at least one magnesium salt, wherein the Ocimum sanctum extract to the Phaseolus vulgaris extract weight ratio is in a range of 1:0.75 to 1:5. The compositions of the present disclosure are effective in treating mood-related disorders. The disclosure also describes a process of preparation of said herbal composition.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. NAIR, Divya Radhakrishnan
2. KAUSHAL, Deepti
3. KALSI, Gurpreet
4. CHITTUR, Lakshmanan Chandrashekharan
Specification
I/We Claim:
1. A composition comprising:
a) Ocimum sanctum extract;
b) Phaseolus vulgaris extract; and
c) at least one magnesium salt,
wherein the Ocimum sanctum extract to the Phaseolus vulgaris extract weight ratio is in a range of 1:0.75 to 1:5.
2. The composition as claimed in claim 1, wherein the at least one magnesium salt is
selected from a group consisting of magnesium chloride, magnesium carbonate,
magnesium sulphate, magnesium gluconate, magnesium phosphate dibasic/tribasic,
and combinations thereof.
3. The composition as claimed in claim 1, wherein the Phaseolus vulgaris extract has a weight percentage in a range of 0.07-0.25% with respect to the composition.
4. The composition as claimed in claim 1, wherein the Ocimum sanctum extract has a weight percentage in a range of 0.025-0.15% with respect to the composition.
5. The composition as claimed in claim 1, wherein the at least one magnesium salt has a weight percentage in a range of 0.5-1% with respect to the composition.
6. The composition as claimed in claim 1, wherein the Ocimum sanctum extract comprises tannins having a weight percentage in a range of 5-10% with respect to the Ocimum sanctum extract.
7. The composition as claimed in claim 1, wherein the Phaseolus vulgaris extract has alpha amylase inhibitory activity in a range of 10,000 IU/g to 15,000 IU/g.
8. The composition as claimed in claim 1, wherein the composition further comprises at least one excipient selected from a group consisting of diluent, carrier, preservative, and combinations thereof.
9. A process for preparing the composition as claimed in claim 1, said process comprising:
a) obtaining the Ocimum sanctum extract;
b) obtaining the Phaseolus vulgaris extract;
c) obtaining the at least one magnesium salt;
d) contacting the Ocimum sanctum extract, the Phaseolus vulgaris extract, and the at least one magnesium salt to obtain the composition.
10. A process for preparing the composition as claimed in claim 8, said process comprising:
a) obtaining the Ocimum sanctum extract;
b) obtaining the Phaseolus vulgaris extract;
c) obtaining the at least one magnesium salt;
d) obtaining the at least one excipient; and
e) contacting the Ocimum sanctum extract, the Phaseolus vulgaris extract, the at least one magnesium salt, and the at least one excipient, to obtain the composition.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201941012738-STATEMENT OF UNDERTAKING (FORM 3) [29-03-2019(online)].pdf | 2019-03-29 |
| 2 | 201941012738-SEQUENCE LISTING(PDF) [29-03-2019(online)].pdf | 2019-03-29 |
| 3 | 201941012738-SEQUENCE LISTING [29-03-2019(online)].txt | 2019-03-29 |
| 4 | 201941012738-FORM 1 [29-03-2019(online)].pdf | 2019-03-29 |
| 5 | 201941012738-DRAWINGS [29-03-2019(online)].pdf | 2019-03-29 |
| 6 | 201941012738-DECLARATION OF INVENTORSHIP (FORM 5) [29-03-2019(online)].pdf | 2019-03-29 |
| 7 | 201941012738-COMPLETE SPECIFICATION [29-03-2019(online)].pdf | 2019-03-29 |
| 8 | 201941012738-Proof of Right (MANDATORY) [21-06-2019(online)].pdf | 2019-06-21 |
| 9 | 201941012738-FORM-26 [21-06-2019(online)].pdf | 2019-06-21 |
| 10 | Correspondence by Agent _Form-1,Power of Attorney_24-06-2019.pdf | 2019-06-24 |
| 11 | 201941012738-FORM 18 [22-03-2023(online)].pdf | 2023-03-22 |